Articles Tagged With:
-
Predictive Accuracy of the New Risk Equation
An evaluation of the predictive accuracy of the new pooled Cohort Risk Equation in > 300,000 subjects without heart disease or diabetes and a low-density lipoprotein cholesterol level between 70-189 mg/dL followed for five years showed that the new equation markedly overestimated the observed risk of cardiovascular events.
-
Arterial Ischemic Stroke Prevention and Risk Factor Management
MONOGRAPH: Here is the best evidence-based practice for stroke diagnosis, prevention, and risk factor management.
-
Experts: Act Quickly to Fight the Rise of Antibiotic Resistance
More innovation is needed to combat the increase in antibiotic resistance, health experts told Congress.
-
Compliance Mentor - June 2016
-
Data Show Improvements in Patient Safety, but More Work Is Needed
Rates of patient harm have decreased by 4.5% per year since 2010, but there are still hurdles to overcome.
-
Dangers of the ED
Prepare yourself and your ED for future large-scale disasters. -
Promising Results for Treating Glioblastoma
New data opens door to important treatment previously unavailable to certain patients.
-
Hoping for the Best, Preparing for the Worst
Dems force Senate’s hand on gun votes as healthcare industry trains for next large-scale emergency.
-
Clinical Briefs
In this section: Might a pharmacologic agent that improves insulin resistance be effective in secondary prevention of CV events?; subclinical thyroid disease status associated with mortality in elders; and is there an infectious disease that causes pathological aggression?
-
Buprenorphine Implant for Subdermal Administration (Probuphine)
The FDA has approved the first buprenorphine implant for the treatment of opioid dependence.